Billions of people worldwide suffer from chronic wounds, surgical wounds, burns, and trauma every year. The number of non-healing wound cases and expenditures are expected to rise as a natural consequence of an increasing population of the elderly and diabetic, as well as the prevalence of cardiovascular disease.

Wound dressings have steadily advanced in recent decades to treat patients more effectively and comprehensively. Advanced wound dressings, in particular, have been adept at fluid management, antimicrobial control, and physical protection. These comprise alginates, collagens, foams, hydrocolloids, hydrofibers, hydrogels, and semi-permeable films.

Wound care companies also market absorptive advanced dressing brands incorporated with antimicrobials for broad-spectrum activity. The silicone-coated dressings have been widely used to prevent trauma to wounds and the surrounding skin, while minimising pain.

The global advanced wound dressings market is valued at $4.7bn in 2017. It is expanding at a compound annual growth rate (CAGR) of 3.9% and is forecast to reach $6.1bn by 2024.